Immunic, Inc.'s CALLIPER study showed vidofludimus calcium reduced disability progression by 30% in PPMS patients, despite modest MRI results, suggesting strong neuroprotective effects. IMUX stock's ...
A study examining subjective experiences after intranasal application of 5-MeO-DMT found that its effects peak 8-15 minutes ...